Mark Leschly - Net Worth and Insider Trading
Mark Leschly Net Worth
The estimated net worth of Mark Leschly is at least $0 dollars as of 2024-11-29. Mark Leschly is the Director of Anacor Pharmaceuticals Inc and owns about 0 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $0. Mark Leschly is also the Director of Senomyx Inc and owns about 0 shares of Senomyx Inc (SNMX) stock worth over $0. Details can be seen in Mark Leschly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Leschly has not made any transactions after 2014-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Leschly
Mark Leschly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Leschly owns 12 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Cara Therapeutics Inc (CARA) , and IntraLinks Holdings Inc (IL) among others .
Click here to see the complete history of Mark Leschly’s form 4 insider trades.
Insider Ownership Summary of Mark Leschly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2019-04-03 | director |
| CARA | Cara Therapeutics Inc | 2016-03-16 | 10 percent owner |
| IL | IntraLinks Holdings Inc | 2017-01-19 | 10 percent owner |
 | | 2016-12-03 | 10 percent owner |
| | 2016-06-24 | director |
| | 2015-02-17 | 10 percent owner |
| | 2015-01-02 | 10 percent owner |
| | 2012-11-28 | 10 percent owner |
| | 2007-05-31 | director |
| | 2006-11-06 | 10 percent owner |
| | 2021-02-02 | 10 percent owner |
| | 2021-02-26 | director |
Mark Leschly Latest Holdings Summary
Mark Leschly currently owns a total of 2 stocks. Among these stocks, Mark Leschly owns 0 shares of Anacor Pharmaceuticals Inc (ANAC) as of August 27, 2014, with a value of $0 . Mark Leschly also owns 0 shares of Senomyx Inc (SNMX) as of November 2, 2006, with a value of $0 .
Latest Holdings of Mark Leschly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2014-08-27 | 0 | 9.82 | 0 |
| SNMX | Senomyx Inc | 2006-11-02 | 0 | 1.49 | 0 |
Holding Weightings of Mark Leschly
Mark Leschly Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Leschly has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 13,067 shares on August 27, 2014, which brought Mark Leschly around $294,008.
According to the SEC Form 4 filings, Mark Leschly has made a total of 0 transactions in Senomyx Inc (SNMX) over the past 5 years. The most-recent trade in Senomyx Inc is the sale of 17,875 shares on November 2, 2006, which brought Mark Leschly around $270,270.
Insider Trading History of Mark Leschly
- 1
Mark Leschly Trading Performance
GuruFocus tracks the stock performance after each of Mark Leschly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Leschly is 53.41%. GuruFocus also compares Mark Leschly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Leschly within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Leschly's insider trading performs compared to the benchmark.
Performance of Mark Leschly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.4 | | | | | |
| Relative Return to S&P 500(%) | 4.25 | | | | | |
Mark Leschly Ownership Network
Mark Leschly Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Mark Leschly is the director of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Mark Leschly made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Mark Leschly Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Leschly. You might contact Mark Leschly via mailing address: Rho Capital Partners, Inc., 152 W 57th St 23rd Fl, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
